Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective NR2B antagonists

Selective NR2B antagonists

US Patent 10501451 · Granted Dec 10, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinazolinyl compounds useful as T cell activators2025
Heterocyclic PAD4 inhibitors2025
Substituted piperazine derivatives useful as T cell activators2025
Substituted amide compounds useful as farnesoid X receptor modulators2025
Substituted bicyclic compounds as farnesoid X receptor modulators2025
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RI2024
Aminotriazolopyridines as kinase inhibitors2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use2024
Indazole carboxamides as kinase inhibitors2024
Biaryl kinase inhibitors2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use2024
Substituted amide compounds useful as farnesoid X receptor modulators2024